Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
J Am Coll Cardiol
    April 2025
  1. BORROWMAN JD, Huang X, Petito LC, Perak AM, et al
    Prepregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife.
    J Am Coll Cardiol. 2025;85:1536-1546.
    >> Share

    December 2024
  2. SPERLING LS
    The "Ticking Clock" of Impending Diabetes: Cause for Concern or Window of Opportunity?
    J Am Coll Cardiol. 2024;84:2260-2263.
    >> Share

  3. GYLDENKERNE C, Kahlert J, Thrane PG, Olesen KKW, et al
    2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.
    J Am Coll Cardiol. 2024;84:2251-2259.
    >> Share

    November 2024
  4. SANTOS-PARDO I, Andersson Franko M, Nystrom T
    Reply: Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024;84:e321.
    >> Share

  5. LIU C, Li X, Cong H
    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024;84:e319-e320.
    >> Share

  6. WARRAICH HJ, Patrick-Lake B, Saha A, Rashid L, et al
    Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration.
    J Am Coll Cardiol. 2024 Nov 19:S0735-1097(24)10028.
    >> Share

  7. PATEL KV, Chunawala Z, Verma S, Segar MW, et al
    Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study.
    J Am Coll Cardiol. 2024 Nov 5:S0735-1097(24)10417.
    >> Share

    September 2024
  8. MENTZ RJ, Kittipibul V
    Improving Health Status With SGLT2 Inhibitors Following Worsening Heart Failure: Fighting an Uphill Battle.
    J Am Coll Cardiol. 2024;84:1089-1091.
    >> Share

  9. BHATT AS, Bhatt DL, Steg PG, Szarek M, et al
    Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF.
    J Am Coll Cardiol. 2024;84:1078-1088.
    >> Share

  10. EVERETT BM, Wexler DJ
    Finding Truth in Observational and Interventional Studies in Diabetes and Cardiovascular Disease.
    J Am Coll Cardiol. 2024;84:918-920.
    >> Share

  11. KHERA R, Aminorroaya A, Dhingra LS, Thangaraj PM, et al
    Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.
    J Am Coll Cardiol. 2024;84:904-917.
    >> Share

    August 2024
  12. MANUBOLU VS, Lakshmanan S, Kinninger A, Ahmad K, et al
    Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes: Insights From the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) Randomized Trial.
    J Am Coll Cardiol. 2024;84:865-867.
    >> Share

  13. NEUEN BL, Ostrominski JW, Claggett B, Beldhuis IE, et al
    Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2024 Aug 26:S0735-1097(24)08155.
    >> Share

  14. PRATLEY RE, Tuttle KR, Rossing P, Rasmussen S, et al
    Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial.
    J Am Coll Cardiol. 2024 Aug 23:S0735-1097(24)08116.
    >> Share

  15. NEUEN BL, Solomon SD
    Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes.
    J Am Coll Cardiol. 2024;84:709-711.
    >> Share

  16. EDMONSTON D, Mulder H, Lydon E, Chiswell K, et al
    Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.
    J Am Coll Cardiol. 2024;84:696-708.
    >> Share

  17. SHIN JI, Xu Y, Chang AR, Carrero JJ, et al
    Prescription Patterns for Sodium-Glucose Cotransporter 2 Inhibitors in U.S. Health Systems.
    J Am Coll Cardiol. 2024;84:683-693.
    >> Share

  18. OSTROMINSKI JW, Jemma Cho SM, Vaduganathan M, Honigberg MC, et al
    Cardiorenal Outcomes in Middle-Aged and Older Adults With Type 1 and Type 2 Diabetes.
    J Am Coll Cardiol. 2024 Aug 7:S0735-1097(24)07747.
    >> Share

  19. INZUCCHI SE, Arai AE
    Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes.
    J Am Coll Cardiol. 2024;84:558-560.
    >> Share

  20. CHOWDHARY A, Thirunavukarasu S, Joseph T, Jex N, et al
    Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2024;84:540-557.
    >> Share

    July 2024
  21. MARINHO LL, Everett BM, Aday AW, Visseren FLJ, et al
    Effect of Pemafibrate on Diabetic Foot Ulceration and Gangrene: An Exploratory Analysis From PROMINENT.
    J Am Coll Cardiol. 2024;84:408-410.
    >> Share

  22. BABER U
    Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter?
    J Am Coll Cardiol. 2024;84:273-275.
    >> Share

  23. GUGLIN M, Hillerson D
    Exploring Racial and Ethnic Differences in Diabetic Cardiomyopathy: The Physical Burden of Health Disparities.
    J Am Coll Cardiol. 2024;84:244-246.
    >> Share

  24. LOPEZ J, Liu Y, Butler J, Del Prato S, et al
    Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
    J Am Coll Cardiol. 2024;84:233-243.
    >> Share

    June 2024
  25. VERMA S, Butler J, Borlaug BA, Davies M, et al
    Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials.
    J Am Coll Cardiol. 2024 Jun 19:S0735-1097(24)07445.
    >> Share

  26. PINNEY SP, Costanzo MR
    As Good as it Gets: SGLT2 Inhibitors in Cardiac Amyloidosis.
    J Am Coll Cardiol. 2024;83:2423-2425.
    >> Share

  27. LALA A, Mentz RJ, Santos-Gallego CG
    The Quest for Understanding Diabetic Cardiomyopathy: Can We Preserve Function and Prevent Failure?
    J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07407.
    >> Share

    May 2024
  28. SANTOS-PARDO I, Andersson Franko M, Lagerqvist B, Ritsinger V, et al
    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024 May 7:S0735-1097(24)06933.
    >> Share

    April 2024
  29. BONACA MP, Bhatt DL, Simon T, Fox KM, et al
    Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.
    J Am Coll Cardiol. 2024;83:1627-1636.
    >> Share

  30. KITTIPIBUL V, Cox ZL, Chesdachai S, Fiuzat M, et al
    Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1568-1578.
    >> Share

  31. WONG ND, Fan W, Hu X, Ballantyne C, et al
    Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
    J Am Coll Cardiol. 2024;83:1511-1525.
    >> Share

  32. BURCHILL LJ, Jain CC, Miranda WR
    Advancing New Solutions for Adult Congenital Heart Disease-Related Heart Failure.
    J Am Coll Cardiol. 2024;83:1415-1417.
    >> Share

  33. PACKER M
    SGLT2 Inhibition: Neither a Diuretic nor a Natriuretic.
    J Am Coll Cardiol. 2024;83:1399-1402.
    >> Share

  34. MARTON A, Saffari SE, Rauh M, Sun RN, et al
    Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
    J Am Coll Cardiol. 2024;83:1386-1398.
    >> Share

  35. NEIJENHUIS RML, MacDonald ST, Zemrak F, Mertens BJA, et al
    Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease.
    J Am Coll Cardiol. 2024;83:1403-1414.
    >> Share

  36. COSTANZO MR, Januzzi JL
    Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
    J Am Coll Cardiol. 2024;83:1307-1309.
    >> Share

  37. JANUZZI JL JR, Butler J, Del Prato S, Ezekowitz JA, et al
    Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
    J Am Coll Cardiol. 2024 Apr 3:S0735-1097(24)06613.
    >> Share

    March 2024
  38. CHATUR S, Vaduganathan M, Claggett B, Solomon SD, et al
    Reply: Rethinking eGFR Comparisons in SGLT2 Inhibitor Research.
    J Am Coll Cardiol. 2024;83:e89.
    >> Share

  39. OHSHIRO Y
    Rethinking eGFR Comparisons in SGLT2 Inhibitor Research.
    J Am Coll Cardiol. 2024;83:e87.
    >> Share

  40. HANSEN MK, Olesen KKW, Gyldenkerne C, Thrane PG, et al
    Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:956-958.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016